Hillevi Larsson

1.1k total citations
13 papers, 926 citations indexed

About

Hillevi Larsson is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Surgery. According to data from OpenAlex, Hillevi Larsson has authored 13 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Hillevi Larsson's work include Diabetes Treatment and Management (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Hillevi Larsson is often cited by papers focused on Diabetes Treatment and Management (5 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Hillevi Larsson collaborates with scholars based in Sweden and Switzerland. Hillevi Larsson's co-authors include Bo Åhrén, Peter Båvenholm, Erik Simonsson, Mona Landin‐Olsson, Per‐Anders Jansson, Sheila Dickinson, David Holmes, Madeléne Sandqvist, Suad Efendić and Jan W. Eriksson and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Hillevi Larsson

13 papers receiving 887 citations

Peers

Countries citing papers authored by Hillevi Larsson

Since Specialization

Citations

This map shows the geographic impact of Hillevi Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillevi Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillevi Larsson more than expected).

Fields of papers citing papers by Hillevi Larsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hillevi Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillevi Larsson. The network helps show where Hillevi Larsson may publish in the future.

Co-authorship network of co-authors of Hillevi Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Hillevi Larsson. A scholar is included among the top collaborators of Hillevi Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillevi Larsson. Hillevi Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A Nationwide Structure for Valid Long-Term Oxygen Therapy: 29 year prospective data in Sweden 2017 ·Zainab Ahmadi, Hillevi Larsson, Tove Nilsson, (unknown), Kerstin Ström, Bengt Midgren, Magnus Ekström	1
2	Insulin Sensitivity, Insulin Secretion, and Glucose ToleranceVersusIntima-Media Thickness in Nondiabetic Postmenopausal Women 2003 ·The Journal of Clinical Endocrinology & Metabolism ·Hillevi Larsson, Göran Berglund, Bo Åhrén	15
3	Inhibition of Dipeptidyl Peptidase IV Improves Metabolic Control Over a 4-Week Study Period in Type 2 Diabetes 2002 ·Diabetes Care ·Bo Åhrén, Erik Simonsson, Hillevi Larsson, Mona Landin‐Olsson, (unknown), Per‐Anders Jansson, Madeléne Sandqvist, Peter Båvenholm, Suad Efendić, Jan W. Eriksson, Sheila Dickinson, David Holmes	357
4	Quantification of Insulin Secretion in Relation to Insulin Sensitivity in Nondiabetic Postmenopausal Women 2002 ·Diabetes ·Bo Åhrén, Hillevi Larsson	39
5	Prediction of diabetes using fasting or 2h glucose in post-menopausal women. A ten-year follow-up study 2000 ·Diabetes Research and Clinical Practice ·Bo Åhrén, Hillevi Larsson, Folke Lindgärde, Göran Berglund	1
6	Evidence for Leptin Regulation of Food Intake in Humans¹ 1998 ·The Journal of Clinical Endocrinology & Metabolism ·Hillevi Larsson, Sölve Elmståhl, Göran Berglund, Bo Åhrén	73
7	Regulation of circulating leptin in humans 1997 ·Endocrine ·Bo Åhrén, Hillevi Larsson, (unknown), Birgitta Näsman, Tommy Olsson	73
8	GLP-1 Tablet in Type 2 Diabetes in Fasting and Postprandial Conditions 1997 ·Diabetes Care ·M. Gutniak, Hillevi Larsson, Steven W. Sanders, (unknown), Jens J. Holst, Bo Åhrén	73
9	Islet dysfunction in obese women with impaired glucose tolerance 1996 ·Metabolism ·Hillevi Larsson, Bo Ahrén	41
10	Androgen Activity as a Risk Factor for Impaired Glucose Tolerance in Postmenopausal Women 1996 ·Diabetes Care ·Hillevi Larsson, Bo Åhrén	37
11	Potential Therapeutic Levels of Glucagon-Like Peptide I Achieved in Humans by a Buccal Tablet 1996 ·Diabetes Care ·M. Gutniak, Hillevi Larsson, (unknown), (unknown), Jens J. Holst, Bo Åhrén	85
12	Plasma Leptin Levels Correlate to Islet Function Independently of Body Fat in Postmenopausal Women 1996 ·Diabetes ·Hillevi Larsson, (unknown), Bo Åhrén	119
13	Effects of Arginine on the Secretion of Insulin and Islet Amyloid Polypeptide in Humans 1995 ·Pancreas ·Hillevi Larsson, Bo Åhrén	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact